Amikacin

Amikacin

Catalog Number:
M001342377TOK
Mfr. No.:
TOK-A002
Price:
$222
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Amikacin is semi-synthetic, broad-spectrum aminoglycoside antibiotic derived from its counterpart, Kanamycin A. Amikacin was patented in 1971 and came into commercial use in 1976. The presence of the amino-hydroxy-butyryl group prevents enzymatic modification of Amikacin at multiple positions. This renders Amikacin a more effective decontaminating agent, as microorganisms which develop resistance to other aminoglycosides remain susceptible to Amikacin. This also gives Amikacin a broader spectrum than the other aminoglycosides currently in use. Amikacin is one of the most common aminoglycosides in veterinary research. It is commonly used in antimicrobial susceptibility testing.
          Amikacin is freely soluble in water.2) (A003)

          Please contact us at for specific academic pricing.

          Background

          Amikacin binds to the 30S ribosomal subunit (specifically the 16S rRNA and S12 protein) resulting in interference with the translational initiation complex and mRNA misreading, which leads to a faulty or nonexistent protein.

      • Properties
        • CAS Number
          37517-28-5
          Molecular Formula
          C22H43N5O13
          Molecular Weight
          585.60 (anhydrous basis)
          Appearance
          White or almost white powder
          Solubility
          Freely soluble in water (50 mg/ml)
          Other Properties
          Source: Semi-synthetic
          Water Content (Karl Fischer): ≤8.5%
          PH: 9.5 - 11.5
          Assay: (On Dried Basis): ≥900µg/mg
          Residue On Ignition: ≤1.0%
          Optical Rotation: +97° to +105°
          Identification: Passes test
          Storage
          2-8°C

          * For research use only

      • Applications
        • Application Description
          Spectrum: Active against Gram-negative and Gram-positive bacteria. Mycobacterium tuberculosis is also susceptible to Amikacin.

          Microbiology Applications: Amikacin is commonly used in clinical in vitro microbiological antimicrobial susceptibility tests (panels, discs, and MIC strips) and rapid antimicrobial testing platforms like the Vitek 2 from Biomerieux against Gram-negative microbial isolates. Medical microbiologists use this information to recommend antibiotic treatment options. Samples of microbes grown in presence of a 30 µg Amikacin discs with a zone of inhibition of <14 mm in diameter are considered resistant. Intermediate resistance zones of inhibition are typically 15 mm-16 mm in diameter. Representative MIC values include:
          Pseudomonas aeruginosa 0.25 µg/mL -512 µg/mL
          Serratia marcescens ≤0.25 µg/mL - >32 µg/mL

          Eukaryotic Cell Culture Applications: Amikacin demonstrates lysosomal phospholipidosis in vitro, with the compound binding to the phospholipid bilayer.
          An LC–MS/MS assay was developed to quantify Amikacin in different biological matrices. This technology can facilitate future studies on improving Amikacin-associated nephrotoxicity. It would be useful for in vitro studies characterizing Amikacin uptake kinetics in renal cells, and in vivo pharmacokinetic studies (Chan et al, 2020).
          Contamination of cell cultures for virus isolation is problematic. Amikacin (and vancomycin) were chosen to replace the penicillin and gentamicin used conventionally. This combination was not toxic to cell cultures remained stable in media for over six months. Virus isolation rate was maintained and contamination was reduced from 10% to 1.5%. This combination can be used for maintenance and transport media to control the emerging problem of viral culture contamination (Lo et el, 1996).

    Documents

    MSDS-EU

    Susceptibility and Resistance Data

    Note: If you don't receive our verification email, do the following:

  • Copyright © Amerigo Scientific. All rights reserved.